SCHEMBL8047044

SCHEMBL8047044

O=C(CCCN1C(=O)c2ccccc2C1=O)N1CCCNC1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.72
LMNA P02545 4/20 0.62
SMN1; SMN2 Q16637 3/20 0.61
ALDH1A1 P00352 10/20 0.60
HPGD P15428 5/20 0.60
HSD17B10 Q99714 3/20 0.60
KMT2A Q03164 2/20 0.60
GAA P10253 1/20 0.60
MAPT P10636 5/20 0.59
NPSR1 Q6W5P4 1/20 0.59
MAPK1 P28482 2/20 0.56
HTT P42858 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.55
KDM4E B2RXH2 3/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C19 P33261 1/20 0.50
ALOX15 P16050 1/20 0.49
TSHR P16473 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29364005 0.84 ACHE (1.00) ACHELMNASMN1; SMN2ALDH1A1HPGD
SCHEMBL3455527 0.79 ACHE (0.89) ACHELMNASMN1; SMN2ALDH1A1HPGD
SCHEMBL11016624 0.78 HTR1A (0.55)
SCHEMBL769680 0.76 SMN1; SMN2 (0.71) ACHELMNASMN1; SMN2ALDH1A1HPGD
SCHEMBL13531591 0.76 ALDH1A1 (1.00) ACHELMNASMN1; SMN2ALDH1A1HPGD
SCHEMBL20816052 0.76 ALDH1A1 (1.00) ACHELMNASMN1; SMN2ALDH1A1HPGD
SCHEMBL16384130 0.73 ACHE (0.78) ACHELMNASMN1; SMN2ALDH1A1HPGD
SCHEMBL11992516 0.73 ACHE (0.69) ACHELMNASMN1; SMN2ALDH1A1HPGD
SCHEMBL770678 0.72 ALDH1A1 (0.71) ACHELMNASMN1; SMN2ALDH1A1HPGD
SCHEMBL15186919 0.72 ALDH1A1 (0.73) ACHELMNASMN1; SMN2ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0765866-B1 Preparation of optically active (S)-(-) and (R)-(+)- deoxyspergualin and novel intermediates thereof BRISTOL MYERS SQUIBB CO (US) 2000-12-06 EP disclosed
EP-0765866-A2 Preparation of optically active (S)-(-) and (R)-(+)- deoxyspergualin and novel intermediates thereof BRISTOL-MYERS SQUIBB COMPANY (US) 1997-04-02 EP disclosed